Nicolas D.
- Country
- France
- Department
- ICU
Research Overview
- Efficacy of early intravenous high-dose vitamin C in post-cardiac arrest shock: a multicenter, randomized controled to standard treatment, open label trial.
- Evaluation of Hydrocortisone and Argipressin Efficacy on 30-Day Survival and Neurological Outcomes in Post-Resuscitation Syndrome with Hemodynamic Failure
- Efficacy of Ivabradine Hydrochloride in Heart Rate Control and 28-Day Survival in Adult Patients with Septic Shock: A Randomized, Multi-Stage Trial
Data & Insights
Has run more than one trial at 14 of 51 partner sites.
Specializations
Cardiac Emergency Medicine
The investigator specializes in treating post-cardiac arrest conditions with particular emphasis on managing post-resuscitation syndrome and associated hemodynamic complications.
- Post-cardiac arrest shock management
- Vasopressor therapy optimization
- High-dose vitamin C interventions
Research activities focus on innovative therapeutic approaches for improving survival outcomes in cardiac arrest patients.
Critical Care Medicine
Expertise extends to treating severe septic shock conditions, with research investigating novel heart rate control interventions and mortality reduction strategies.
- Hemodynamic management
- Heart rate control therapies
- Shock treatment protocols
Clinical work encompasses advanced critical care interventions for patients with severe systemic infections.
Immunology in Critical Care
The investigator addresses ICU-acquired immunosuppression through innovative immunotherapy approaches and infection prevention strategies.
- Immunotherapy applications
- Secondary infection prevention
- Immune system monitoring
Research explores standardized immunotherapy protocols for critically ill patients with compromised immune function.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.